Related Experiment Video
Updated: Sep 19, 2025

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Exploring Causal Effects of Hormone- and Radio-Treatments in an Observational Study of Breast Cancer Using
Tonghui Yu1, Mengjiao Peng2, Yifan Cui3
1School of Physical and Mathematical Sciences, Nanyang Technological University, Singapore, Singapore.
Abstract:
Breast cancer patients may experience relapse or death after surgery during the follow-up period, leading to dependent censoring of relapse. This phenomenon, known as semi-competing risk, imposes challenges in analyzing treatment effects on breast cancer and necessitates advanced statistical tools for unbiased analysis. Despite progress in estimation and inference within semi-competing risks regression, its application to causal inference is still in its early stages. This article aims to propose a frequentist and semi-parametric framework based on copula models that can facilitate valid causal inference, net quantity estimation and interpretation, and sensitivity analysis for unmeasured factors under right-censored semi-competing risks data. We also propose novel procedures to enhance parameter estimation and its applicability in practice. After that, we apply the proposed framework to a breast cancer study and detect the time-varying causal effects of hormone- and radio-treatments on patients' relapse and overall survival. Moreover, extensive numerical evaluations demonstrate the method's feasibility, highlighting minimal estimation bias and reliable statistical inference.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Comparing the Survival Analysis of Two or More Groups
Criteria for Causality: Bradford Hill Criteria - II
Cancer Survival Analysis
Causality in Epidemiology
Hazard Ratio
For example, in a clinical trial...

